IL-10 Expression-Inducing Gut Bacteria Alleviate High-Fat Diet-Induced Obesity and Hyperlipidemia in Mice

J Microbiol Biotechnol. 2020 Apr 28;30(4):599-603. doi: 10.4014/jmb.1912.12014.

Abstract

In the present study, we examined the effects of interleukin (IL)-10 expression-inducing bacteria Bifidobacterium adolescentis HP1, Lactobacillus mucosae HP2, and Weissella cibaria HP3 on high-fat diet (HFD)-induced obesity and liver steatosis in mice. Oral gavage of HP1, HP2, and HP3 reduced HFD-induced bodyweight gain, triglycerides, and total cholesterol levels in the blood and liver. They also suppressed HFD-induced colitis and the fecal δ,γ-Proteobacteria population. Of the tested bacteria, HP2, which most potently inhibited IL-10 expression, also suppressed HFD-induced bodyweight gain, liver steatosis, and colitis most effectively. These findings suggest that IL-10 expression-inducing gut bacteria can suppress obesity and liver steatosis.

Keywords: Gut bacteria; IL-10; colitis; liver steatosis; obesity.

MeSH terms

  • Animals
  • Bifidobacterium adolescentis / physiology
  • Colitis / drug therapy
  • Colitis / etiology
  • Colitis / metabolism
  • Diet, High-Fat / adverse effects*
  • Fatty Liver / drug therapy
  • Fatty Liver / etiology
  • Fatty Liver / metabolism
  • Gastrointestinal Microbiome / drug effects
  • Gastrointestinal Microbiome / physiology*
  • Hyperlipidemias / drug therapy*
  • Hyperlipidemias / etiology
  • Hyperlipidemias / metabolism
  • Interleukin-10 / metabolism*
  • Lactobacillus / physiology
  • Liver / drug effects
  • Liver / metabolism
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Obesity / drug therapy*
  • Obesity / etiology
  • Obesity / metabolism
  • Probiotics / administration & dosage
  • Probiotics / pharmacology
  • Weight Gain / drug effects
  • Weissella / physiology

Substances

  • IL10 protein, mouse
  • Interleukin-10

Supplementary concepts

  • Lactobacillus mucosae
  • Weissella cibaria